Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: a modelling studyResearch in context

Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: a modelling studyResearch in context

Summary: Background: The current recommendation for MenACWY vaccination against invasive meningococcal disease (IMD) in the United States (US) includes two doses: the first dose at ages 11–12 and a booster dose at age 16. The Advisory Committee on Immunization Practices has proposed options for rev...

Full description

Bibliographic Details
Main Authors: Affan Shoukat, Chad R. Wells, Thomas Shin, Lilia Potter-Schwartz, Alison P. Galvani, Seyed M. Moghadas
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:The Lancet Regional Health. Americas
Subjects:
Meningococcal disease
Transmission dynamics
MenACWY vaccination
Simulation
Online Access:http://www.sciencedirect.com/science/article/pii/S2667193X25000432

Internet

http://www.sciencedirect.com/science/article/pii/S2667193X25000432

Similar Items